{"id":864,"date":"2026-05-25T03:49:51","date_gmt":"2026-05-25T03:49:51","guid":{"rendered":"https:\/\/wuhantopmiraclepeptides.com\/?post_type=product&p=864"},"modified":"2026-07-11T11:52:23","modified_gmt":"2026-07-11T11:52:23","slug":"cjc-1295-ipamorelin-blend-10mg","status":"publish","type":"product","link":"https:\/\/wuhantopmiraclepeptides.com\/index.php\/product\/cjc-1295-ipamorelin-blend-10mg\/","title":{"rendered":"CJC-1295 & Ipamorelin Blend (10mg)"},"content":{"rendered":"

CJC-1295 & Ipamorelin Blend (10mg) Research Peptide: A Synergistic GH & IGF-1 Research Tool<\/span><\/h1>\n

If your research explores the hypothalamic-pituitary-somatotropic axis, the dynamics of growth hormone (GH) secretion, or the downstream effects of insulin-like growth factor 1 (IGF-1), the\u00a0<\/span>CJC-1295 & Ipamorelin Blend (10mg) research peptide<\/span><\/strong>\u00a0offers a precisely defined, dual-pathway experimental platform. This 10 mg formulation combines two well\u2011characterised GH secretagogues\u2014<\/span>CJC-1295 (Mod GRF 1-29)<\/span><\/strong>\u00a0and\u00a0<\/span>Ipamorelin<\/span><\/strong>\u2014each acting through complementary mechanisms to stimulate the body’s natural GH release<\/span>.\u00a0<\/span><\/p>\n

By simultaneously targeting the GHRH receptor and the ghrelin receptor (GHS-R1a), this blend allows researchers to model the synergistic interplay between these two major regulatory pathways, providing deeper insight into the circuits that govern GH pulsatility and IGF-1 signalling<\/span>. <\/span><\/p>\n

At\u00a0<\/span>Wuhan Top Miracle Peptides<\/span><\/strong>, we supply high\u2011purity\u00a0<\/span>CJC-1295 & Ipamorelin Blend (10mg) research peptide<\/span><\/strong>\u00a0to research institutions and wholesale buyers across the\u00a0<\/span>United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA<\/span><\/strong>. Every batch is lyophilised, HPLC\u2011verified to \u226598% purity, and accompanied by a Certificate of Analysis (COA)<\/span>, ensuring your investigations into GH regulation, IGF\u20111 signalling, and metabolic research begin with uncompromising quality.<\/span><\/p>\n

What Is the CJC-1295 & Ipamorelin Blend and How Does It Work?<\/span><\/h2>\n

To fully appreciate the research potential of the\u00a0<\/span>CJC-1295 & Ipamorelin Blend (10mg) research peptide<\/span><\/strong>, it is essential to understand the distinct yet complementary mechanisms of its two components<\/span>. Each peptide activates a different receptor class, yet both converge on the somatotroph cells of the anterior pituitary to stimulate GH synthesis and release<\/span>.<\/span><\/p>\n

CJC-1295 (Mod GRF 1-29): The Stabilised GHRH Analogue<\/span><\/h3>\n

CJC-1295 in this blend is the\u00a0<\/span>“no DAC”<\/span><\/strong>\u00a0(Drug Affinity Complex) variant, also referred to as\u00a0<\/span>Modified GRF 1-29<\/span><\/strong>. It is a synthetic peptide derived from the 29-amino-acid fragment of human growth hormone-releasing hormone (GHRH)<\/span>. CJC-1295 features four specific amino acid substitutions\u2014at positions 2, 8, 15, and 27\u2014that enhance its stability and render it resistant to enzymatic degradation<\/span>. <\/span><\/p>\n

As a GHRH analogue, it binds to GHRH receptors (GHRHR) on pituitary somatotroph cells<\/span>, stimulating the synthesis and pulsatile release of endogenous growth hormone<\/span>. The “no DAC” variant has a half-life of approximately\u00a0<\/span>30 minutes<\/span><\/strong>\u00a0and produces sharp, natural GH spikes that mimic the body’s own pulsatile rhythm<\/span>, making it the preferred form for protocols that aim to replicate physiological GH secretion<\/span>.<\/span><\/p>\n

Ipamorelin: The Selective Ghrelin Receptor Agonist<\/span><\/h3>\n

Ipamorelin is a synthetic pentapeptide classified as a selective growth hormone secretagogue<\/span>. It was first described in the\u00a0<\/span>European Journal of Endocrinology<\/span><\/em>\u00a0as “the first selective growth hormone secretagogue.” Ipamorelin binds to the ghrelin receptor (GHS-R1a), a class A GPCR expressed on somatotrophs and hypothalamic neurons<\/span>. A key research advantage is its\u00a0<\/span>selectivity<\/span><\/strong>: it stimulates GH release without significantly elevating cortisol, ACTH, or prolactin<\/span>, even at doses well above those required for GH stimulation<\/span>. This high specificity distinguishes it from earlier, non-selective secretagogues and makes it a cleaner tool for studying GH dynamics<\/span>.<\/span><\/p>\n

Mechanism of Synergy: Dual\u2011Pathway Activation<\/span><\/h3>\n

The scientific rationale for combining CJC\u20111295 and Ipamorelin lies in their convergent yet distinct mechanisms<\/span>. CJC\u20111295 binds to the GHRH receptor and signals via the\u00a0<\/span>cAMP\/PKA pathway<\/span><\/strong>, driving GH synthesis and transcriptional priming. Ipamorelin, on the other hand, binds to the ghrelin receptor and signals via the\u00a0<\/span>Ca\u00b2\u207a\/PKC pathway<\/span><\/strong>, triggering immediate GH exocytosis<\/span>. <\/span><\/p>\n

When co\u2011activated, these two pathways converge on the somatotroph to produce GH pulses with\u00a0<\/span>both larger amplitude and greater secretory reserve<\/span><\/strong>\u00a0than either pathway alone<\/span>. This dual-pathway co-activation yields a synergistic GH response\u2014studies have shown that the combination produces up to\u00a0<\/span>3\u20135 times higher GH release<\/span><\/strong>\u00a0than either peptide alone<\/span>. The combined-stack rationale\u2014GHRH analogue plus ghrelin receptor agonist\u2014was established in the 1990s and has since become the dominant design in growth-hormone peptide research<\/span>.<\/span><\/p>\n

Key Research Applications for the CJC-1295 & Ipamorelin Blend (10mg)<\/span><\/h2>\n

The\u00a0<\/span>CJC-1295 & Ipamorelin Blend (10mg) research peptide<\/span><\/strong>\u00a0is a versatile tool with applications spanning several domains of biomedical research<\/span>.<\/span><\/p>\n

1. Growth Hormone Axis & Pituitary Function Studies<\/span><\/h3>\n

This blend provides a powerful model for investigating the hypothalamic\u2011pituitary\u2011somatotropic axis<\/span>. Researchers can use it to study:<\/span><\/p>\n